Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EDAP TMS SAFOCL · Entity 6325 | Director | August 14, 2026 | August 17, 2026 |
| EXELIXIS, INC.EXEL · Entity 3386 | Director | May 26, 2022 | May 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EDAP TMS SA
Report date August 14, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,291,780 |
Reported balance
After 2026-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-14 · Purchase · Acquired 50,000 · Balance 1,291,780 F1: Common Stock for the issuer refers to the issuer's ordinary shares. F2: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock for the issuer refers to the issuer's ordinary shares.
F2: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer.
EXELIXIS, INC.
Report date May 26, 2022 · Filed May 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.19 · Expires 2029-05-25 | Direct | 42,422 |
Reported balance
After 2022-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 42,422 · Balance 42,422 F1: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 17, 2026 10:01 UTC | EDAP TMS SA FOCL · Entity 6325 | PurchaseCommon Stock | 50,000 | $4.75 | $237,500.00 |
DisclosureSEC source: 0001829126-26-008923 · ownership.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,291,780 F1 · security: Common Stock for the issuer refers to the issuer's ordinary shares. F2 · security: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer. Read SEC document |
| May 12, 2026 Filed May 13, 2026 10:04 UTC | EDAP TMS SA EDAP · Entity 6325 | GrantStock Options · Derivative | 114,285 | $0.00 Strike: $4.17 | $0.00 |
DisclosureSEC source: 0001829126-26-005045 · ownership.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,285 Underlying: Common Stock · 114,285 shares Expires 2036-05-12 F1 · derivative.exercise_price: The option exercise price reflected was converted from 3.54 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1784. F2 · derivative.exercise_date: The options, which were granted on May 12, 2026, will become exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and the remaining five-sixths of the options will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant. F3 · derivative.underlying: Common Stock for the issuer refers to the issuer's ordinary shares. Read SEC document |
| May 26, 2022 Filed May 28, 2022 00:24 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 42,422 | $0.00 Strike: $18.19 | $0.00 |
DisclosureSEC source: 0000939767-22-000075 · wf-form4_165369746567501.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,422 Underlying: Common Stock · 42,422 shares Expires 2029-05-25 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 12, 2022 Filed May 14, 2022 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0000939767-22-000059 · wf-form4_165248698120896.xml · derivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. Read SEC document |
| May 12, 2022 Filed May 14, 2022 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $19.65 | $786,000.00 |
DisclosureSEC source: 0000939767-22-000059 · wf-form4_165248698120896.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,415 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.47 to $19.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 12, 2022 Filed May 14, 2022 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.13 | $125,200.00 |
DisclosureSEC source: 0000939767-22-000059 · wf-form4_165248698120896.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 33,549 | $0.00 Strike: $22.48 | $0.00 |
DisclosureSEC source: 0000939767-21-000065 · wf-form4_162224835853171.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,549 Underlying: Common Stock · 33,549 shares Expires 2028-05-26 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000939767-21-000023 · wf-form4_161421549385793.xml · derivative · entry 5 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 800 | $22.34 | $17,872.00 |
DisclosureSEC source: 0000939767-21-000023 · wf-form4_161421549385793.xml · nonDerivative · entry 4 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,415 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.31 to $22.37. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 39,200 | $21.92 | $859,264.00 |
DisclosureSEC source: 0000939767-21-000023 · wf-form4_161421549385793.xml · nonDerivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,215 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.31 to $22.30. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.38 | $135,200.00 |
DisclosureSEC source: 0000939767-21-000023 · wf-form4_161421549385793.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 25, 2021 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 50,000 | $21.90 | $1,095,000.00 |
DisclosureSEC source: 0000939767-21-000023 · wf-form4_161421549385793.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,415 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.83 to $21.98. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:56 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 106,142 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000159 · wf-form4_160712977816539.xml · derivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,142 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 106,142 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| December 04, 2020 Filed Dec 5, 2020 00:56 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 106,142 | $5.82 | $617,746.44 |
DisclosureSEC source: 0000939767-20-000159 · wf-form4_160712977816539.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 30,750 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0000939767-20-000096 · wf-form4_159019579773491.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,750 Underlying: Common Stock · 30,750 shares Expires 2027-05-20 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 18, 2020 Filed May 21, 2020 00:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0000939767-20-000087 · wf-form4_159002139669707.xml · derivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. Read SEC document |
| May 18, 2020 Filed May 21, 2020 00:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 30,000 | $26.26 | $787,800.00 |
DisclosureSEC source: 0000939767-20-000087 · wf-form4_159002139669707.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.25 to $26.26. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 18, 2020 Filed May 21, 2020 00:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 30,000 | $4.58 | $137,400.00 |
DisclosureSEC source: 0000939767-20-000087 · wf-form4_159002139669707.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 16, 2020 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0000939767-20-000082 · wf-form4_158958835920163.xml · derivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010. Read SEC document |
| May 14, 2020 Filed May 16, 2020 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 15,000 | $25.26 | $378,900.00 |
DisclosureSEC source: 0000939767-20-000082 · wf-form4_158958835920163.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.23 to $25.32. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 14, 2020 Filed May 16, 2020 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $5.92 | $88,800.00 |
DisclosureSEC source: 0000939767-20-000082 · wf-form4_158958835920163.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 42,641 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-19-000128 · wf-form4_155874413638293.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,641 Underlying: Common Stock · 42,641 shares Expires 2026-05-22 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 08, 2019 Filed May 11, 2019 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 50,000 | $20.36 | $1,018,000.00 |
DisclosureSEC source: 0000939767-19-000118 · wf-form4_155753399415415.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.28 to $20.50. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 00:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0000939767-19-000047 · wf-form4_155088200783323.xml · derivative · entry 5 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 00:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 11,250 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000939767-19-000047 · wf-form4_155088200783323.xml · derivative · entry 4 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 00:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 26,250 | $21.11 | $554,137.50 |
DisclosureSEC source: 0000939767-19-000047 · wf-form4_155088200783323.xml · nonDerivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.10 to $21.16. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 00:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $4.57 | $68,550.00 |
DisclosureSEC source: 0000939767-19-000047 · wf-form4_155088200783323.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 00:33 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 11,250 | $4.16 | $46,800.00 |
DisclosureSEC source: 0000939767-19-000047 · wf-form4_155088200783323.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:24 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000106 · wf-form4_152720783720964.xml · derivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F2 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 22, 2018 Filed May 25, 2018 00:24 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 50,000 | $21.40 | $1,070,000.00 |
DisclosureSEC source: 0000939767-18-000106 · wf-form4_152720783720964.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.26 to $21.60. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · derivative · entry 5 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 18, 2011. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · derivative · entry 4 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 30,000 | $23.91 | $717,300.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.86 to $23.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 3, 2018 01:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000032 · wf-form4_152003889726794.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 23:18 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 50,000 | $26.97 | $1,348,500.00 |
DisclosureSEC source: 0000939767-17-000149 · wf-form4_150543109685590.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,273 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.29. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 23:18 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 50,000 | $26.79 | $1,339,500.00 |
DisclosureSEC source: 0000939767-17-000149 · wf-form4_150543109685590.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.59 to $26.94. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4 Read SEC document |
| May 25, 2017 Filed May 27, 2017 00:46 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 23,491 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0000939767-17-000109 · wf-form4_149584598827096.xml · derivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,491 Underlying: Common Stock · 23,491 shares Expires 2024-05-24 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · derivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 10,000 | $22.86 | $228,600.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.85 to $22.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.